David W. Newstrom

407 total citations
6 papers, 294 citations indexed

About

David W. Newstrom is a scholar working on Molecular Biology, Cancer Research and Endocrine and Autonomic Systems. According to data from OpenAlex, David W. Newstrom has authored 6 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Cancer Research and 1 paper in Endocrine and Autonomic Systems. Recurrent topics in David W. Newstrom's work include NF-κB Signaling Pathways (2 papers), Mast cells and histamine (1 paper) and Hypothalamic control of reproductive hormones (1 paper). David W. Newstrom is often cited by papers focused on NF-κB Signaling Pathways (2 papers), Mast cells and histamine (1 paper) and Hypothalamic control of reproductive hormones (1 paper). David W. Newstrom collaborates with scholars based in United States. David W. Newstrom's co-authors include Stephanie M. Correa, James P. Warne, Allison Xu, Pierre Flandin, Andrew A. Pierce, Holly A. Ingraham, John L.R. Rubenstein, Clement C. Cheung, Kathy Liu and Bruno Marchand and has published in prestigious journals such as Hepatology, Journal of Hepatology and Cell Reports.

In The Last Decade

David W. Newstrom

5 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David W. Newstrom United States	4	119	76	64	62	53	6	294
Charles Kresge United States	12	64 0.5×	225 3.0×	76 1.2×	37 0.6×	34 0.6×	16	500
J. N. O'Reilly Australia	12	100 0.8×	170 2.2×	70 1.1×	7 0.1×	63 1.2×	16	379
Nicholas K. Smith United States	8	30 0.3×	179 2.4×	7 0.1×	27 0.4×	50 0.9×	12	396
Maria Sol Rodríguez-Peña Spain	11	71 0.6×	249 3.3×	8 0.1×	22 0.4×	94 1.8×	14	398
Sukanta Jash United States	13	94 0.8×	163 2.1×	8 0.1×	10 0.2×	133 2.5×	24	367
M. L. Schubert United States	13	141 1.2×	212 2.8×	11 0.2×	36 0.6×	50 0.9×	19	552
Qiu-Jie Zhao China	5	27 0.2×	148 1.9×	19 0.3×	10 0.2×	56 1.1×	5	371
E. Mutel France	7	53 0.4×	165 2.2×	5 0.1×	33 0.5×	146 2.8×	7	369
Kyung Jin Roh South Korea	9	110 0.9×	183 2.4×	42 0.7×	5 0.1×	37 0.7×	17	405

Countries citing papers authored by David W. Newstrom

Since Specialization

Citations

This map shows the geographic impact of David W. Newstrom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Newstrom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Newstrom more than expected).

Fields of papers citing papers by David W. Newstrom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Newstrom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Newstrom. The network helps show where David W. Newstrom may publish in the future.

Co-authorship network of co-authors of David W. Newstrom

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Newstrom. A scholar is included among the top collaborators of David W. Newstrom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Newstrom. David W. Newstrom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Pohlmeyer, Christopher W., Ching Shang, Zhi-Hua Cui, et al.. (2021). Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis. BMC Rheumatology. 5(1). 15–15. 10 indexed citations

2.

Bates, Jamie, Archana Vijayakumar, Sarani Ghoshal, et al.. (2020). Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation. Journal of Hepatology. 73(4). 896–905. 154 indexed citations

3.

Bates, Jamie, David Hollenback, Anna Zagórska, et al.. (2018). Combination of an FXR agonist and an ACC inhibitor increases anti-fibrotic efficacy in rodent models of NASH. Journal of Hepatology. 68. S395–S396.

4.

Wei, Ling, David Hollenback, Saritha Kusam, et al.. (2018). ACC inhibitor demonstrates potent anti-fibrotic activity in vitro and in vivo. Journal of Hepatology. 68. S399–S400. 2 indexed citations

5.

Karnik, Satyajit, Michael R. Charlton, Li Li, et al.. (2015). efficacy of an Ask1 Inhibitor to Reduce Fibrosis and Steatosis in a Murine Model of Nash is Associated with Normalization of Lipids and Hepatic Gene Expression and a Reduction in Serum Biomarkers of Inflammation and Fibrosis : 1359. Hepatology. 62. 6 indexed citations

6.

Correa, Stephanie M., David W. Newstrom, James P. Warne, et al.. (2014). An Estrogen-Responsive Module in the Ventromedial Hypothalamus Selectively Drives Sex-Specific Activity in Females. Cell Reports. 10(1). 62–74. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact